Patent · US Active

Factor VII composition

US9029316B2 · kind B2 · utility

3Cited by

0References

19Claims

0Family size

Assignee

Laboratoire Francais du Fractionnement et des Biotechnologies · FR

Inventors

Annie Bardat · Gif-sur-Yvette, FR
Cornelius Pompe · Munich, DE

Key dates

Filing date	Jun 18, 2010
Grant date	May 12, 2015
Priority date	—
Expiry date	Jun 18, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/21021
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a stable pharmaceutical composition in liquid form or in solid form, comprising factor VII, said composition being free of mannitol and of sucrose, or even also of any antioxidant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.